Cdkn3 - cyclin-dependent kinase inhibitor 3 Gene
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 289993
Summary
Predicted to enable protein serine/threonine Phosphatase activity and protein tyrosine Phosphatase activity. Predicted to be involved in peptidyl-tyrosine dephosphorylation. Predicted to act upstream of or within regulation of cell cycle. Predicted to be located in cytosol and perinuclear region of cytoplasm. Predicted to be active in cytoplasm. Human ortholog(s) of this gene implicated in hepatocellular carcinoma. Orthologous to human CDKN3 (cyclin dependent kinase inhibitor 3). [provided by Alliance of Genome Resources, Apr 2022]
Cdkn3 Products (2)
| mRNA | Protein | Name |
|---|---|---|
| NM_001106028.1 | NP_001099498.1 | cyclin-dependent kinase inhibitor 3 isoform 2 |
| NM_001401040.1 | NP_001387969.1 | cyclin-dependent kinase inhibitor 3 isoform 1 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
cyclin-dependent kinase inhibitor 3 |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS02419 | CDKN3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS20878 | Cdkn3 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS27395 | Cdkn3 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service